Cathro recruits fraud, forensic accounting specialist – AccountantsDaily

Corporate restructuring specialist Cathro & Partners has recruited Mark Cook to bolster its insolvency and advisory practice. Already have an account? Sign in below: Cathro said Mr Cook had two decades of experience in forensic accounting, fraud investigation, corporate restructuring advisory, and insolvency in both Australia and the UK. His expertise complements the firms three…

Debt Consolidation Vs. Bankruptcy – Business Insider

Regardless of your debt relief of choice, they should be part of a larger plan to remain debt-free.Giuseppe Lombardo/Getty JUMP TO Section Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options. Difference between debt settlement and debt consolidation Debt settlement Debt consolidation Debt settlement vs debt consolidation Frequently…

Scotland's Insolvencies Surge as Businesses Struggle with Soaring … – Global Village space

The number of Scottish companies filing for administration has seen a significant increase, reflecting the impact of rising costs and economic uncertainty. According to a study conducted by Interpath Advisory, based on notices in The Gazette, Scotland witnessed a total of 23 companies falling into administration in Q2 2023, compared to just 3 companies in…

AgriFORCE Provides Business Update Following Restructuring of … – GlobeNewswire

VANCOUVER, British Columbia, July 24, 2023 (GLOBE NEWSWIRE) — AgriFORCE Growing Systems Ltd. (the Company) (NASDAQ: AGRI; AGRIW), an agtech company focused on advancing sustainable cultivation and plant-based products, today provided a business update following the recent restructuring of management. Richard Wong, interim CEO of AgriFORCE, stated, We remain committed to pursuing business opportunities that…

Heron Therapeutics Announces Cost Reduction Plan and … – PR Newswire

– Expected overall cash savings of $75 million through 2025– New executive management team in place SAN DIEGO, July 24, 2023 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced a cost reduction plan and…